Class ICompletedD-0493-2025
Drug recall · June 25, 2025
UMOVY ACIDO HIALURONICO recall
Why: Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone and Diclofenac.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
UMOVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, UPC 7503046054134
- Lots / codes
All Lots; All Expiration Dates.
- Quantity
- 1,704 30-count bottles
- Company
- Umary-USA.com, Nogales, AZ
- Distribution
- U.S. Nationwide via internet.
- Initiated
- May 21, 2025 · Voluntary: Firm initiated
- Classified
- June 24, 2025
- Reported
- June 25, 2025
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.